In our study, the average age at the start of hGH treatment was at 99.06 ± 8.07 months, in contrast to the current clinical practice guidelines for the care of girls and women with Turner syndrome, which recommend starting at 48–72 months of age (6). This evidence concerns the gene GH1 and Turner syndrome.